{"id":"W3213036992","doi":"10.3389/fcvm.2021.789931","title":"Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol","year":2021,"lang":"en","type":"review","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ezetimibe; Medicine; Statin; Drug; PCSK9; Cholesterol; Clinical trial; Pharmacology; Adverse effect; Residual risk; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004449789,0.0005227894,0.001150715,0.001568394,0.0001894905,0.0007130165,0.0006028903,0.0005985866,0.004863045],"category_scores_gemma":[0.0006367954,0.0001543105,0.0007308515,0.00111728,0.0001982469,0.0007251243,0.0004293253,0.001165563,0.0013969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003628492,"about_ca_system_score_gemma":0.0007787154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000658549,"about_ca_topic_score_gemma":0.001821347,"domain_scores_codex":[0.9998232,0.00003477729,0.00003440683,0.00002883898,0.00006074142,0.00001804959],"domain_scores_gemma":[0.9997947,0.000101916,0.00003530132,0.000004927007,0.0000490751,0.00001417492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001050934,0.00006228172,0.0001439423,0.04098202,0.0001866169,0.0001570755,0.00006495381,0.0001796647,0.001410823,0.002525512,0.01536166,0.9388204],"study_design_scores_gemma":[0.00005134935,0.0002124735,0.001421491,0.01689737,0.0005287076,0.001528753,0.00009239808,0.0001131517,0.000484795,0.001749745,0.9768999,0.0000199908],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001776163,0.9986537,0.00007510433,0.0001943886,0.0001090457,0.000006438423,0.00002453618,0.000006089188,0.0007530609],"genre_scores_gemma":[0.0006984777,0.9986138,0.0001434851,0.000144464,0.00007251176,0.000006352604,0.00002926953,8.306049e-7,0.0002907281],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004863045,"threshold_uncertainty_score":0.01626855,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02993258624970574,"score_gpt":0.3200143753985646,"score_spread":0.2900817891488589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}